Embolotherapy for nonneoplastic vascular diseases including hemorrhage and congenital vascular malformations is reviewed. Application of short, intermediate, and long-acting embolic materials to these conditions is presented along with potential complications associated with their misuse. Successful application of embolotherapy results from a thorough understanding of the disease process being treated, the distinctive features of the circulation to be embolized, and the embolic material used for the occlusion.
No takes yet. Share an insight, caveat, or question.
RI White (1984) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: